Xometry’s (XMTR) “Market Outperform” Rating Reiterated at JMP Securities

Xometry (NASDAQ:XMTRGet Free Report)‘s stock had its “market outperform” rating restated by research analysts at JMP Securities in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $30.00 price objective on the stock. JMP Securities’ price target indicates a potential upside of 77.62% from the stock’s current price.

Several other equities research analysts have also commented on the company. The Goldman Sachs Group cut their target price on Xometry from $46.00 to $28.00 and set a “buy” rating on the stock in a research report on Friday, March 1st. TheStreet lowered Xometry from a “c-” rating to a “d” rating in a report on Thursday, February 29th. Royal Bank of Canada dropped their price target on Xometry from $38.00 to $23.00 and set a “sector perform” rating on the stock in a report on Friday, March 1st. Finally, UBS Group decreased their target price on Xometry from $22.00 to $21.00 and set a “neutral” rating for the company in a research report on Wednesday, March 13th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Xometry currently has an average rating of “Moderate Buy” and an average target price of $26.67.

View Our Latest Research Report on XMTR

Xometry Price Performance

Xometry stock opened at $16.89 on Tuesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 4.25 and a current ratio of 4.28. Xometry has a 52 week low of $12.45 and a 52 week high of $38.74. The stock has a market capitalization of $820.52 million, a P/E ratio of -12.06 and a beta of 0.71. The stock has a fifty day moving average of $19.97 and a 200-day moving average of $23.75.

Xometry (NASDAQ:XMTRGet Free Report) last issued its earnings results on Thursday, February 29th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Xometry had a negative return on equity of 17.34% and a negative net margin of 14.56%. The firm had revenue of $128.15 million during the quarter, compared to analyst estimates of $127.78 million. On average, sell-side analysts expect that Xometry will post -0.64 earnings per share for the current fiscal year.

Insider Activity

In other Xometry news, COO Peter Goguen sold 3,943 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $17.61, for a total transaction of $69,436.23. Following the completion of the transaction, the chief operating officer now owns 197,211 shares of the company’s stock, valued at approximately $3,472,885.71. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Xometry news, COO Peter Goguen sold 3,943 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $17.61, for a total transaction of $69,436.23. Following the transaction, the chief operating officer now owns 197,211 shares in the company, valued at approximately $3,472,885.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO James M. Rallo sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $30.85, for a total value of $154,250.00. Following the transaction, the chief financial officer now owns 44,381 shares in the company, valued at approximately $1,369,153.85. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,243 shares of company stock valued at $279,642. Insiders own 19.23% of the company’s stock.

Institutional Trading of Xometry

Several hedge funds and other institutional investors have recently made changes to their positions in XMTR. Raymond James & Associates lifted its position in Xometry by 4.1% in the 1st quarter. Raymond James & Associates now owns 287,299 shares of the company’s stock valued at $4,852,000 after acquiring an additional 11,276 shares in the last quarter. Vanguard Group Inc. lifted its position in Xometry by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 3,800,370 shares of the company’s stock valued at $136,471,000 after acquiring an additional 26,718 shares in the last quarter. Wellington Management Group LLP bought a new position in Xometry in the 4th quarter valued at approximately $21,165,000. Austin Wealth Management LLC bought a new position in Xometry in the 4th quarter valued at approximately $646,000. Finally, Primecap Management Co. CA lifted its position in Xometry by 0.3% in the 4th quarter. Primecap Management Co. CA now owns 6,652,858 shares of the company’s stock valued at $238,904,000 after acquiring an additional 21,647 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Xometry Company Profile

(Get Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Further Reading

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.